These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 9302689

  • 1. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
    Evans SC, Lozano G.
    Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
    [Abstract] [Full Text] [Related]

  • 2. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ.
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [Abstract] [Full Text] [Related]

  • 3. [Li-Fraumeni syndrome].
    Frebourg T.
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [Abstract] [Full Text] [Related]

  • 4. [Germline mutations of the p53 gene].
    Frebourg T.
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [Abstract] [Full Text] [Related]

  • 5. High frequency of de novo mutations in Li-Fraumeni syndrome.
    Gonzalez KD, Buzin CH, Noltner KA, Gu D, Li W, Malkin D, Sommer SS.
    J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
    [Abstract] [Full Text] [Related]

  • 6. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR, Da Rocha JC, Vettore AL, Hainaut P.
    Cancer Lett; 2007 Jan 08; 245(1-2):96-102. PubMed ID: 16494995
    [Abstract] [Full Text] [Related]

  • 7. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
    Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, Tricker KJ, Varley JM.
    Oncogene; 1998 Sep 03; 17(9):1061-8. PubMed ID: 9764816
    [Abstract] [Full Text] [Related]

  • 8. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.
    Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P.
    Curr Opin Oncol; 2010 Jan 03; 22(1):64-9. PubMed ID: 19952748
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Familial gastric cancer and Li-Fraumeni syndrome.
    Corso G, Pedrazzani C, Marrelli D, Pinto E, Roviello F.
    Eur J Cancer Care (Engl); 2010 May 03; 19(3):377-81. PubMed ID: 19674071
    [Abstract] [Full Text] [Related]

  • 11. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ, Santibáñez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G.
    Oncogene; 1994 Nov 03; 9(11):3273-80. PubMed ID: 7936651
    [Abstract] [Full Text] [Related]

  • 12. Germline TP53 mutations and Li-Fraumeni syndrome.
    Varley JM.
    Hum Mutat; 2003 Mar 03; 21(3):313-20. PubMed ID: 12619118
    [Abstract] [Full Text] [Related]

  • 13. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA.
    Cancer Res; 2003 Oct 15; 63(20):6643-50. PubMed ID: 14583457
    [Abstract] [Full Text] [Related]

  • 14. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A, Vazna A, Hrachovina O, Bendova S, Prochazkova K, Sedlacek Z.
    Cancer Genet Cytogenet; 2009 Aug 15; 193(1):63-6. PubMed ID: 19602465
    [Abstract] [Full Text] [Related]

  • 15. Cancer risks from germ line tumor suppressor gene mutations.
    Frebourg T, Malkin D, Friend S.
    Princess Takamatsu Symp; 1991 Aug 15; 22():61-70. PubMed ID: 1844252
    [Abstract] [Full Text] [Related]

  • 16. Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family.
    Varley JM, Chapman P, McGown G, Thorncroft M, White GR, Greaves MJ, Scott D, Spreadborough A, Tricker KJ, Birch JM, Evans DG, Reddel R, Camplejohn RS, Burn J, Boyle JM.
    Oncogene; 1998 Jun 25; 16(25):3291-8. PubMed ID: 9681828
    [Abstract] [Full Text] [Related]

  • 17. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
    Barlow JW, Mous M, Wiley JC, Varley JM, Lozano G, Strong LC, Malkin D.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 25; 13(8):1403-6. PubMed ID: 15298965
    [Abstract] [Full Text] [Related]

  • 18. [Li-Fraumeni syndrome and germ-line mutations of the p53 gene].
    Leblanc T, Soussi T.
    Arch Pediatr; 1994 Jan 25; 1(1):61-70. PubMed ID: 8087224
    [Abstract] [Full Text] [Related]

  • 19. Germ-line splicing mutation of the p53 gene in a cancer-prone family.
    Warneford SG, Witton LJ, Townsend ML, Rowe PB, Reddel RR, Dalla-Pozza L, Symonds G.
    Cell Growth Differ; 1992 Nov 25; 3(11):839-46. PubMed ID: 1467311
    [Abstract] [Full Text] [Related]

  • 20. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
    Landolsi S, Gharbi O, Zrig M, Gribaa M, Njim L, Zakhama A, Abid A, Frébourg T, Ahmed SB.
    Ann Biol Clin (Paris); 2010 Nov 25; 68(3):346-50. PubMed ID: 20478780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.